HCmed Innovations Co., Ltd. (TPE:6934)

Taiwan · Delayed Price · Currency is TWD

74.20

+1.10 (1.50%)

At close: Aug 25, 2026

HCmed Innovations Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	109.19	100.23	141.61	9.24	6.48	54.06
Revenue Growth	-18.28%	-29.22%	1433.43%	42.56%	-88.02%	67.23%
Gross Profit	11.62	24.92	99.65	-26.15	-30.77	34.65
Operating Income	-129.94	-119.69	-37.59	-143.76	-146	-40.87
Net Income	-124.61	-126.11	-78.21	-165.93	-143.79	-40.19
Earnings Per Share	-3.66	-3.92	-2.60	-6.25	-6.66	-2.29
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
America	74.39	123.98	6.29
Asia	1.88	3.64	1.91
Europe	23.88	13.99	1.03
Africa	0.08	-	-
Total	100.23	141.61	9.24

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	423.89	263.55	175.83	243.61	123.5	48.49
Total Debt	102.49	111.95	8.84	16.25	3.6	9.15
Net Cash (Debt)	321.4	151.6	166.99	227.37	119.9	39.34
Net Cash Growth	47.40%	-9.21%	-26.55%	89.63%	204.77%	-53.13%
Net Cash Per Share	9.43	4.72	5.56	8.56	5.55	2.24

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-100.12	-66.13	-32.54	-111.61	-80.4	-19.82
Capital Expenditures	-59.1	-58.07	-10.84	-16.12	-7.55	-
Free Cash Flow	-159.22	-124.2	-43.38	-127.74	-87.95	-19.82
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	10.64%	24.86%	70.37%	-283.14%	-	64.10%
Operating Margin	-119.00%	-119.41%	-26.55%	-1556.70%	-2253.83%	-75.60%
Pretax Margin	-114.11%	-128.43%	-35.96%	-1801.80%	-2223.29%	-74.34%
Profit Margin	-114.12%	-125.82%	-55.23%	-1796.71%	-2219.67%	-74.34%
FCF Margin	-145.81%	-123.91%	-30.63%	-1383.17%	-1357.64%	-36.67%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	24.44	29.02	17.54	-	-	-